Learn More
Biocare Medical, LLC ERG 0.1ML

Supplier: Biocare Medical, LLC CM421A
ERG has a 99.9% specificity for detecting prostatic adenocarcinomas. It does not stain lymphocytes. There is a 96.5% concordance of ERG positive PIN and ERG positive carcinoma in prostatectomy specimens. PATENT PENDING.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.